Suppr超能文献

饮食模式对非酒精性脂肪性肝病患者肝脏脂肪变性、纤维化及生化指标的影响:一项随机对照临床试验

The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial.

作者信息

Alizadeh Mohammad, Hosseiniazar Mohammadreza Mohammad, Alami Farkhondeh, Bararnia Adabi Somayyeh

机构信息

Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran.

Department of Internal Medicine, School of Medicine, Taleghani Hospital, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran.

出版信息

J Diabetes Metab Disord. 2024 Jan 5;23(1):987-997. doi: 10.1007/s40200-023-01375-2. eCollection 2024 Jun.

Abstract

BACKGROUND

This study was designed to compare the effects of four meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with Nonalcoholic fatty liver disease (NAFLD).

METHODS

The 12-week intervention was performed on 123 patients with NAFLD who were randomly allocated into four groups: "3-meals", "skipping breakfast", "skipping dinner", and " 3 meals and 3 snacks per day." group. The assessment of liver steatosis, fibrosis, biochemical factors, and anthropometrical evaluation were performed at baseline and at end of the study.

RESULTS

A significant improvement was found in the liver steatosis and fibrosis among the patients who consumed 3 meals, 3 snacks compared to the other groups ( < 0.001). In addition, a higher reduction was observed in serum levels of alanine amino transferase (ALT) (20.93 ± 23.37 mg/dl,  < 0.001), aspartate aminotransferase (AST) (17.15 ± 16.48 mg/dl,  < 0.001), gamma-glutamyl transferase(GGT) (13.43 ± 13.41 mg/dl;  < 0.001), and alkaline phosphatase (ALK) (47.19 ± 60.51 mg/dl;  = 0.004) in patients who consumed 3 meals, 3 snacks, while the concentration of liver enzymes in patients who consumed 3 meals increased significantly. At the end of the study, there was a significant increase in the fasting blood sugar (FBS) concentration in the "skipping breakfast" group (17.51 ± 38.85 mg/dl;  = 0.011) and "3-meals" group (17.51 ± 38.85 mg/dl,  = 0.03).

CONCLUSION

Consuming 3 meals, 3 snack per day significantly improves disease severity and biochemical factors in NAFLD patients. Further studies are warranted.

TRIAL REGISTRATION NUMBER

: IRCT20201010048982N2. Name of the registry: Urmia University of Medical Sciences. Date of registration: 2021-08-22, 1400/05/31. URL of trial registry record: https://www.irct.ir/search/result?query=IRCT20201010048982N2.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s40200-023-01375-2.

摘要

背景

本研究旨在比较四种饮食模式对非酒精性脂肪性肝病(NAFLD)患者肝脏脂肪变性、纤维化和生化指标的影响。

方法

对123例NAFLD患者进行了为期12周的干预,这些患者被随机分为四组:“三餐”组、“不吃早餐”组、“不吃晚餐”组和“每日三餐及三次加餐”组。在基线和研究结束时对肝脏脂肪变性、纤维化、生化指标进行评估,并进行人体测量学评价。

结果

与其他组相比,每日三餐及三次加餐的患者肝脏脂肪变性和纤维化有显著改善(<0.001)。此外,每日三餐及三次加餐的患者血清丙氨酸氨基转移酶(ALT)水平(20.93±23.37mg/dl,<0.001)、天冬氨酸氨基转移酶(AST)水平(17.15±16.48mg/dl,<0.001)、γ-谷氨酰转移酶(GGT)水平(13.43±13.41mg/dl;<0.001)和碱性磷酸酶(ALK)水平(47.19±60.51mg/dl;=0.004)有更大程度的降低,而三餐组患者的肝酶浓度显著升高。在研究结束时,“不吃早餐”组(17.51±38.85mg/dl;=0.011)和“三餐”组(17.51±38.85mg/dl,=0.03)的空腹血糖(FBS)浓度显著升高。

结论

每日三餐及三次加餐可显著改善NAFLD患者的疾病严重程度和生化指标。有必要进行进一步研究。

试验注册号

IRCT20201010048982N2。注册机构名称:乌尔米亚医科大学。注册日期:2021年8月22日,1400/05/31。试验注册记录的网址:https://www.irct.ir/search/result?query=IRCT20201010048982N2。

补充信息

在线版本包含可在10.1007/s40200-023-01375-2获取的补充材料。

相似文献

7
Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
Eur J Pediatr. 2022 Feb;181(2):579-586. doi: 10.1007/s00431-021-04243-4. Epub 2021 Aug 30.

本文引用的文献

1
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
Clin Liver Dis (Hoboken). 2022 Feb 3;19(3):101-105. doi: 10.1002/cld.1172. eCollection 2022 Mar.
2
Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver.
Front Physiol. 2021 Mar 3;12:625352. doi: 10.3389/fphys.2021.625352. eCollection 2021.
3
Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver.
Redox Biol. 2021 May;41:101919. doi: 10.1016/j.redox.2021.101919. Epub 2021 Mar 10.
4
NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States.
J Clin Transl Hepatol. 2020 Jun 28;8(2):215-221. doi: 10.14218/JCTH.2020.00014. Epub 2020 May 29.
5
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH.
Clin Mol Hepatol. 2020 Oct;26(4):383-400. doi: 10.3350/cmh.2020.0067. Epub 2020 Jul 17.
6
The effects of skipping a meal on daily energy intake and diet quality.
Public Health Nutr. 2020 Dec;23(18):3346-3355. doi: 10.1017/S1368980020000683. Epub 2020 May 13.
8
Food as a circadian time cue - evidence from human studies.
Nat Rev Endocrinol. 2020 Apr;16(4):213-223. doi: 10.1038/s41574-020-0318-z. Epub 2020 Feb 13.
9
The Lifestyle Characteristics in Non-Alcoholic Fatty Liver Disease in the PERSIAN Guilan Cohort Study.
Open Access Maced J Med Sci. 2019 Sep 14;7(19):3313-3318. doi: 10.3889/oamjms.2019.647. eCollection 2019 Oct 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验